Category Archives: Pradaxa

Featured Stories
Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Canadian Research Institutions Named Co-Defendants in Pradaxa Lawsuits in U.S.

pradaxa-canadian-research-defendants-in-trial

In an unusual situation, Canada’s McMaster University and Hamilton Health Sciences have been named co-defendants in lawsuits in U.S. federal court over the safety of the blood-thinning drug Pradaxa (dabigatran). The lawsuits allege that tainted data from mismanaged clinical trials … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

More than 2,000 Lawsuits Over Pradaxa Bleeding Risks, Boehringer Confirms

Pradaxa-Bleeding-Dangers

Boehringer Ingelheim, manufacturer of the blood-thinner Pradaxa (dabigatran), has confirmed that it faces more than 2,000 lawsuits in the United States alleging that the drug causes severe and fatal bleeding. The company’s confirmation came after the German newspaper Handelsblatt reported … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

Pradaxa Maker Sought to Revise, Suppress Controversial, Internal Research

pradaxa-maker-suppress-research

The maker of the controversial blood thinner, Pradaxa, was apparently worried that release of an internal study might impact sales. Boehringer Ingleheim employees allegedly pressured the study’s author to revise or suppress the study, according to recently unsealed legal documents, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Boehringer Fined $931,000 Over Lost Pradaxa Files

boehringer-fined-almost-one-million

Boehringer Ingelheim GmbH, which markets and manufactures Pradaxa, has been charged with a nearly $1 million fine, according to a recent ruling. The fine was levied for the drug maker’s withholding or failing to preserve files sought in Pradaxa litigation, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study Finds Pradaxa Risky for Patients Implanted with Artificial Heart Valves

Pradaxa has been tied to more serious adverse reactions, according to a new study on Behringer Ingelheim’s blood thinner. The research revealed that when Pradaxa (dabigatran) is taken by patients with mechanical heart valves, there is an increase in risks … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study: New Blood Thinners Associated with GI Bleed Risk

gi_bleeding_risks

Another study revealed issues related to new anti-coagulants, such as Pradaxa, including serious bleeds. The new study revealed that, based on a pooled analysis of 17 randomized controlled trials (RCTs) there was an increased risk of stomach bleeding in patients … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Pradaxa may Increase Viral Infection Risks, Severity, Study Shows

An new study found that the blood thinner, Pradaxa (dabigatran etexilate mesylate), may increase risks viral infections, as well as increasing the severity of these infections. University of North Carolina researchers discovered that the blood thinner blocks a critical component … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA: Blood Thinner, Pradaxa, Should Not Be Used by Patients with Mechanical Prosthetic Heart Valves

Blood thinner, Pradaxa (dabigatran etexilate mesylate), should not be used to prevent stroke or blood clots in patients implanted with mechanical heart valves. The U.S. Food and Drug Administration (FDA) has recently informed health care professionals and the public of … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Was FDA’s Pradaxa® Analysis Flawed?

Despite a growing number of serious gastrointestinal bleed reports linked to Pradaxa®, the U.S. Food & Drug Administration (FDA) argues that the blood thinner, manufactured by Behringer Ingelheim, is safe when used as directed. Pradaxa® was approved two years ago … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA backs previous stance on Pradaxa bleeding risks

Federal health officials have issued an update on its stance on the new blood thinner drug Pradaxa, indicating the risk of severe bleeding associated with the drug is no more significant than any other drugs available on the market for … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.